25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Alterity Therapeutics Ltd
Buy, Hold or Sell?

Let's analyze Alterity Therapeutics Ltd together

I guess you are interested in Alterity Therapeutics Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Alterity Therapeutics Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Alterity Therapeutics Ltd

I send you an email if I find something interesting about Alterity Therapeutics Ltd.

1. Quick Overview

1.1. Quick analysis of Alterity Therapeutics Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Alterity Therapeutics Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$0.00
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
A$-0.01
Return On Investment
-226.2%

For what price can you sell your share?

Current Price per Share
A$0.00
Expected price per share
A$0.002 - A$0.003
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Alterity Therapeutics Ltd (5 min.)




Live pricePrice per Share (EOD)
A$0.00
Intrinsic Value Per Share
A$-0.04 - A$-0.02
Total Value Per Share
A$-0.04 - A$-0.01

2.2. Growth of Alterity Therapeutics Ltd (5 min.)




Is Alterity Therapeutics Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$9.3m$15.4m-$6m-65.3%

How much money is Alterity Therapeutics Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$12.9m-$9.3m-$3.5m-27.8%
Net Profit Margin0.0%-352.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Alterity Therapeutics Ltd (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#589 / 957

Most Revenue
#457 / 957

Most Profit
#547 / 957

Most Efficient
#644 / 957
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Alterity Therapeutics Ltd?

Welcome investor! Alterity Therapeutics Ltd's management wants to use your money to grow the business. In return you get a share of Alterity Therapeutics Ltd.

First you should know what it really means to hold a share of Alterity Therapeutics Ltd. And how you can make/lose money.

Speculation

The Price per Share of Alterity Therapeutics Ltd is A$0.003. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Alterity Therapeutics Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Alterity Therapeutics Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Alterity Therapeutics Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-81.2%0.00-81.2%0.00-58.6%0.00-28.3%0.00-14.3%
Usd Book Value Change Per Share0.00-38.3%0.00-38.3%0.0095.3%0.0011.6%0.005.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-38.3%0.00-38.3%0.0095.3%0.0011.6%0.005.7%
Usd Price Per Share0.00-0.00-0.00-0.01-0.03-
Price to Earnings Ratio-1.11--1.11--2.69--428.34--2,967.75-
Price-to-Total Gains Ratio-2.36--2.36-1.66-122.41-7,406.64-
Price to Book Ratio1.54-1.54-1.63-302.46-862.98-
Price-to-Total Gains Ratio-2.36--2.36-1.66-122.41-7,406.64-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0020298
Number of shares492659
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (492659 shares)-565.56171.01
Gains per Year (492659 shares)-2,262.23684.04
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-2262-22720684674
20-4524-4534013681358
30-6787-6796020522042
40-9049-9058027362726
50-11311-11320034203410
60-13573-13582041044094
70-15836-15844047884778
80-18098-18106054725462
90-20360-20368061566146
100-22622-22630068406830

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.023.00.00.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%5.05.00.050.0%12.011.00.052.2%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.023.00.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%5.05.00.050.0%12.011.00.052.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Alterity Therapeutics Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.002-0.0020%0.004-140%0.001-431%0.000-772%
Book Value Per Share--0.0030.0030%0.004-40%0.001+85%0.001+257%
Current Ratio--3.5433.5430%6.173-43%6.515-46%9.112-61%
Debt To Asset Ratio--0.2820.2820%0.165+71%0.178+59%0.140+102%
Debt To Equity Ratio--0.3930.3930%0.197+99%0.224+75%0.170+131%
Dividend Per Share----0%-0%-0%-0%
Eps---0.004-0.0040%-0.003-28%-0.001-65%-0.001-82%
Free Cash Flow Per Share---0.002-0.0020%-0.004+59%-0.001-48%-0.001-73%
Free Cash Flow To Equity Per Share---0.001-0.0010%-0.004+487%-0.001+36%0.000-31%
Gross Profit Margin--1.0001.0000%1.0040%1.0020%1.0030%
Intrinsic Value_10Y_max---0.016--------
Intrinsic Value_10Y_min---0.044--------
Intrinsic Value_1Y_max---0.001--------
Intrinsic Value_1Y_min---0.003--------
Intrinsic Value_3Y_max---0.003--------
Intrinsic Value_3Y_min---0.010--------
Intrinsic Value_5Y_max---0.006--------
Intrinsic Value_5Y_min---0.018--------
Market Cap15939720.192-33%21252960.25621252960.2560%37192680.448-43%73322712.883-71%235376534.835-91%
Net Profit Margin----0%-3.5250%-115.2010%-87.1730%
Operating Margin----0%-3.7540%-123.7190%-95.8190%
Operating Ratio----0%4.503-100%121.447-100%95.014-100%
Pb Ratio1.155-33%1.5401.5400%1.630-6%302.461-99%862.983-100%
Pe Ratio-0.834+25%-1.111-1.1110%-2.694+142%-428.337+38442%-2967.746+266938%
Price Per Share0.003-33%0.0040.0040%0.007-43%0.014-71%0.044-91%
Price To Free Cash Flow Ratio-1.264+25%-1.685-1.6850%-1.856+10%-465.379+27516%-2573.870+152634%
Price To Total Gains Ratio-1.768+25%-2.358-2.3580%1.657-242%122.409-102%7406.643-100%
Quick Ratio--3.1043.1040%5.573-44%6.126-49%8.862-65%
Return On Assets---0.995-0.9950%-0.505-49%-0.599-40%-0.471-53%
Return On Equity---1.386-1.3860%-0.605-56%-0.755-46%-0.573-59%
Total Gains Per Share---0.002-0.0020%0.004-140%0.001-431%0.000-772%
Usd Book Value--9335765.3669335765.3660%15435214.229-40%5059768.145+85%2617397.255+257%
Usd Book Value Change Per Share---0.001-0.0010%0.003-140%0.000-431%0.000-772%
Usd Book Value Per Share--0.0020.0020%0.003-40%0.001+85%0.000+257%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.002-0.0020%-0.002-28%-0.001-65%0.000-82%
Usd Free Cash Flow---8532972.024-8532972.0240%-13561193.937+59%-4472960.007-48%-2267179.211-73%
Usd Free Cash Flow Per Share---0.002-0.0020%-0.003+59%-0.001-48%0.000-73%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%-0.003+487%-0.001+36%0.000-31%
Usd Market Cap10784814.682-33%14379752.90914379752.9090%25164567.591-43%49610147.537-71%159255763.469-91%
Usd Price Per Share0.002-33%0.0030.0030%0.005-43%0.009-71%0.030-91%
Usd Profit---12938935.742-12938935.7420%-9341488.049-28%-4508333.148-65%-2282727.157-82%
Usd Revenue----0%2649790.908-100%543043.421-100%272047.320-100%
Usd Total Gains Per Share---0.001-0.0010%0.003-140%0.000-431%0.000-772%
 EOD+3 -5MRQTTM+0 -0YOY+8 -245Y+8 -2410Y+6 -26

3.3 Fundamental Score

Let's check the fundamental score of Alterity Therapeutics Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.834
Price to Book Ratio (EOD)Between0-11.155
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.104
Current Ratio (MRQ)Greater than13.543
Debt to Asset Ratio (MRQ)Less than10.282
Debt to Equity Ratio (MRQ)Less than10.393
Return on Equity (MRQ)Greater than0.15-1.386
Return on Assets (MRQ)Greater than0.05-0.995
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Alterity Therapeutics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.315
Ma 20Greater thanMa 500.003
Ma 50Greater thanMa 1000.004
Ma 100Greater thanMa 2000.004
OpenGreater thanClose0.003
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Alterity Therapeutics Ltd

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that is in Phase I clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy advance; and PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.

Fundamental data was last updated by Penke on 2024-09-13 19:45:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Alterity Therapeutics Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Alterity Therapeutics Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Alterity Therapeutics Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-352.5%+352.5%
TTM-5Y-11,520.1%+11,520.1%
5Y-11,520.1%10Y-8,717.3%-2,802.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--131.4%+131.4%
TTM--212.1%+212.1%
YOY-352.5%-219.3%-133.2%
5Y-11,520.1%-370.1%-11,150.0%
10Y-8,717.3%-487.5%-8,229.8%
4.3.1.2. Return on Assets

Shows how efficient Alterity Therapeutics Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Alterity Therapeutics Ltd to the Biotechnology industry mean.
  • -99.5% Return on Assets means that Alterity Therapeutics Ltd generated $-0.99 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Alterity Therapeutics Ltd:

  • The MRQ is -99.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -99.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-99.5%TTM-99.5%0.0%
TTM-99.5%YOY-50.5%-48.9%
TTM-99.5%5Y-59.9%-39.6%
5Y-59.9%10Y-47.1%-12.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-99.5%-11.0%-88.5%
TTM-99.5%-11.8%-87.7%
YOY-50.5%-11.2%-39.3%
5Y-59.9%-12.8%-47.1%
10Y-47.1%-14.4%-32.7%
4.3.1.3. Return on Equity

Shows how efficient Alterity Therapeutics Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Alterity Therapeutics Ltd to the Biotechnology industry mean.
  • -138.6% Return on Equity means Alterity Therapeutics Ltd generated $-1.39 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Alterity Therapeutics Ltd:

  • The MRQ is -138.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -138.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-138.6%TTM-138.6%0.0%
TTM-138.6%YOY-60.5%-78.1%
TTM-138.6%5Y-75.5%-63.1%
5Y-75.5%10Y-57.3%-18.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-138.6%-13.8%-124.8%
TTM-138.6%-16.1%-122.5%
YOY-60.5%-13.7%-46.8%
5Y-75.5%-18.9%-56.6%
10Y-57.3%-19.1%-38.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Alterity Therapeutics Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Alterity Therapeutics Ltd is operating .

  • Measures how much profit Alterity Therapeutics Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Alterity Therapeutics Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Alterity Therapeutics Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-375.4%+375.4%
TTM-5Y-12,371.9%+12,371.9%
5Y-12,371.9%10Y-9,581.9%-2,789.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--286.0%+286.0%
TTM--305.1%+305.1%
YOY-375.4%-241.7%-133.7%
5Y-12,371.9%-386.0%-11,985.9%
10Y-9,581.9%-495.6%-9,086.3%
4.3.2.2. Operating Ratio

Measures how efficient Alterity Therapeutics Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Alterity Therapeutics Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY4.503-4.503
TTM-5Y121.447-121.447
5Y121.44710Y95.014+26.434
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.760-2.760
TTM-3.284-3.284
YOY4.5033.432+1.071
5Y121.4474.971+116.476
10Y95.0146.542+88.472
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Alterity Therapeutics Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Alterity Therapeutics Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.54 means the company has $3.54 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Alterity Therapeutics Ltd:

  • The MRQ is 3.543. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.543. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.543TTM3.5430.000
TTM3.543YOY6.173-2.630
TTM3.5435Y6.515-2.973
5Y6.51510Y9.112-2.597
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5433.740-0.197
TTM3.5433.919-0.376
YOY6.1734.741+1.432
5Y6.5155.982+0.533
10Y9.1126.336+2.776
4.4.3.2. Quick Ratio

Measures if Alterity Therapeutics Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Alterity Therapeutics Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 3.10 means the company can pay off $3.10 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Alterity Therapeutics Ltd:

  • The MRQ is 3.104. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.104. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.104TTM3.1040.000
TTM3.104YOY5.573-2.469
TTM3.1045Y6.126-3.022
5Y6.12610Y8.862-2.736
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1043.138-0.034
TTM3.1043.448-0.344
YOY5.5734.734+0.839
5Y6.1265.870+0.256
10Y8.8626.481+2.381
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Alterity Therapeutics Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Alterity Therapeutics Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Alterity Therapeutics Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.28 means that Alterity Therapeutics Ltd assets are financed with 28.2% credit (debt) and the remaining percentage (100% - 28.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Alterity Therapeutics Ltd:

  • The MRQ is 0.282. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.282. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.282TTM0.2820.000
TTM0.282YOY0.165+0.117
TTM0.2825Y0.178+0.104
5Y0.17810Y0.140+0.038
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2820.342-0.060
TTM0.2820.345-0.063
YOY0.1650.306-0.141
5Y0.1780.365-0.187
10Y0.1400.380-0.240
4.5.4.2. Debt to Equity Ratio

Measures if Alterity Therapeutics Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Alterity Therapeutics Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 39.3% means that company has $0.39 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Alterity Therapeutics Ltd:

  • The MRQ is 0.393. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.393. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.393TTM0.3930.000
TTM0.393YOY0.197+0.196
TTM0.3935Y0.224+0.169
5Y0.22410Y0.170+0.054
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3930.394-0.001
TTM0.3930.450-0.057
YOY0.1970.372-0.175
5Y0.2240.447-0.223
10Y0.1700.488-0.318
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Alterity Therapeutics Ltd generates.

  • Above 15 is considered overpriced but always compare Alterity Therapeutics Ltd to the Biotechnology industry mean.
  • A PE ratio of -1.11 means the investor is paying $-1.11 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Alterity Therapeutics Ltd:

  • The EOD is -0.834. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.111. Based on the earnings, the company is expensive. -2
  • The TTM is -1.111. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.834MRQ-1.111+0.278
MRQ-1.111TTM-1.1110.000
TTM-1.111YOY-2.694+1.582
TTM-1.1115Y-428.337+427.225
5Y-428.33710Y-2,967.746+2,539.409
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.834-2.318+1.484
MRQ-1.111-2.392+1.281
TTM-1.111-2.971+1.860
YOY-2.694-3.470+0.776
5Y-428.337-6.025-422.312
10Y-2,967.746-6.219-2,961.527
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Alterity Therapeutics Ltd:

  • The EOD is -1.264. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.685. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.685. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.264MRQ-1.685+0.421
MRQ-1.685TTM-1.6850.000
TTM-1.685YOY-1.856+0.170
TTM-1.6855Y-465.379+463.694
5Y-465.37910Y-2,573.870+2,108.491
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.264-3.100+1.836
MRQ-1.685-3.198+1.513
TTM-1.685-3.575+1.890
YOY-1.856-4.670+2.814
5Y-465.379-8.056-457.323
10Y-2,573.870-8.614-2,565.256
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Alterity Therapeutics Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.54 means the investor is paying $1.54 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Alterity Therapeutics Ltd:

  • The EOD is 1.155. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.540. Based on the equity, the company is underpriced. +1
  • The TTM is 1.540. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.155MRQ1.540-0.385
MRQ1.540TTM1.5400.000
TTM1.540YOY1.630-0.090
TTM1.5405Y302.461-300.921
5Y302.46110Y862.983-560.522
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.1551.808-0.653
MRQ1.5401.903-0.363
TTM1.5402.210-0.670
YOY1.6302.407-0.777
5Y302.4613.549+298.912
10Y862.9834.082+858.901
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Alterity Therapeutics Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-06-302021-06-302022-06-302023-06-302024-06-30
Current Deferred Revenue 0000-1-107-10712316



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. All numbers in thousands.

Summary
Total Assets19,224
Total Liabilities5,426
Total Stockholder Equity13,798
 As reported
Total Liabilities 5,426
Total Stockholder Equity+ 13,798
Total Assets = 19,224

Assets

Total Assets19,224
Total Current Assets19,037
Long-term Assets187
Total Current Assets
Cash And Cash Equivalents 12,639
Net Receivables 4,042
Inventory 0
Other Current Assets 2,356
Total Current Assets  (as reported)19,037
Total Current Assets  (calculated)19,037
+/-0
Long-term Assets
Property Plant Equipment 187
Long-term Assets Other 0
Long-term Assets  (as reported)187
Long-term Assets  (calculated)187
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities5,374
Long-term Liabilities52
Total Stockholder Equity13,798
Total Current Liabilities
Short-term Debt 107
Accounts payable 581
Other Current Liabilities 4,670
Total Current Liabilities  (as reported)5,374
Total Current Liabilities  (calculated)5,358
+/- 16
Long-term Liabilities
Long-term Liabilities  (as reported)52
Long-term Liabilities  (calculated)0
+/- 52
Total Stockholder Equity
Common Stock223,153
Retained Earnings -214,161
Accumulated Other Comprehensive Income 4,806
Total Stockholder Equity (as reported)13,798
Total Stockholder Equity (calculated)13,798
+/-0
Other
Cash and Short Term Investments 12,639
Common Stock Shares Outstanding 5,245,115
Current Deferred Revenue16
Liabilities and Stockholders Equity 19,224
Net Debt -12,480
Short Long Term Debt Total 159



5.3. Balance Sheets Structured

All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-301998-06-30
> Total Assets 
199
1,837
20,876
22,287
17,591
16,341
41,164
22,199
10,427
7,721
11,723
4,597
6,801
9,011
7,342
17,074
41,641
41,834
33,725
25,281
18,726
19,910
13,305
33,586
41,363
27,318
19,224
19,22427,31841,36333,58613,30519,91018,72625,28133,72541,83441,64117,0747,3429,0116,8014,59711,7237,72110,42722,19941,16416,34117,59122,28720,8761,837199
   > Total Current Assets 
0
0
4,470
6,855
3,755
3,649
29,565
22,033
10,325
7,673
11,619
4,491
6,708
8,932
7,256
16,983
41,549
41,744
33,657
25,250
18,655
19,861
13,233
33,489
41,144
27,049
19,037
19,03727,04941,14433,48913,23319,86118,65525,25033,65741,74441,54916,9837,2568,9326,7084,49111,6197,67310,32522,03329,5653,6493,7556,8554,47000
       Cash And Cash Equivalents 
0
0
4,470
6,855
3,587
3,454
29,401
21,366
10,020
7,408
11,243
4,305
5,227
8,838
5,636
13,347
34,167
34,910
28,594
21,885
15,236
14,400
9,197
28,116
34,807
15,774
12,639
12,63915,77434,80728,1169,19714,40015,23621,88528,59434,91034,16713,3475,6368,8385,2274,30511,2437,40810,02021,36629,4013,4543,5876,8554,47000
       Short-term Investments 
0
0
0
0
0
0
0
0
42
46
0
0
0
0
0
0
0
153
0
44
10
0
0
0
0
0
0
000000104401530000000464200000000
       Net Receivables 
0
0
0
0
108
143
92
174
194
70
121
1
1
7
1,552
3,526
7,285
6,522
4,787
3,036
3,152
4,829
3,458
4,126
4,669
8,649
4,042
4,0428,6494,6694,1263,4584,8293,1523,0364,7876,5227,2853,5261,55271112170194174921431080000
       Other Current Assets 
0
0
0
0
60
52
1
493
0
26
11
185
1,480
91
67
112
97
153
25
44
0
10
10
1,247
1,668
2,626
2,356
2,3562,6261,6681,2471010044251539711267911,48018511260493152600000
   > Long-term Assets 
0
0
0
0
13,835
12,692
11,598
166
102
48
105
106
94
79
86
91
92
90
68
31
71
49
71
97
219
269
187
1872692199771497131689092918679941061054810216611,59812,69213,8350000
       Property Plant Equipment 
0
0
0
0
140
141
180
166
102
48
69
71
59
41
38
47
48
45
24
31
71
49
71
97
219
269
187
1872692199771497131244548473841597169481021661801411400000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44
0
0
0
0
0
0
0
0
0000000044000000000000000000
       Intangible Assets 
0
0
0
0
13,696
12,551
11,419
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000011,41912,55113,6960000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
35
35
35
38
10
44
0
0
44
-31
-71
-49
-71
-97
-219
-269
0
0-269-219-97-71-49-71-3144004410383535350000000000
> Total Liabilities 
200
1,918
147
895
913
565
2,696
2,684
1,693
2,110
1,836
847
1,572
2,080
1,718
3,099
3,955
2,721
2,358
1,591
2,645
3,355
2,757
3,115
5,894
4,505
5,426
5,4264,5055,8943,1152,7573,3552,6451,5912,3582,7213,9553,0991,7182,0801,5728471,8362,1101,6932,6842,6965659138951471,918200
   > Total Current Liabilities 
0
0
0
0
913
563
2,688
2,639
1,616
1,739
972
799
1,500
2,075
1,711
3,099
3,952
2,719
2,357
1,590
2,644
3,320
2,715
3,068
5,820
4,382
5,374
5,3744,3825,8203,0682,7153,3202,6441,5902,3572,7193,9523,0991,7112,0751,5007999721,7391,6162,6392,6885639130000
       Short-term Debt 
0
0
0
0
0
0
0
0
42
46
0
0
0
286
299
803
0
153
0
44
10
33
33
28
58
107
107
10710758283333104401530803299286000464200000000
       Accounts payable 
0
0
0
0
843
540
2,646
2,561
953
460
851
604
1,244
659
202
279
3,358
362
312
65
1,334
1,694
954
1,449
2,662
1,716
581
5811,7162,6621,4499541,6941,334653123623,3582792026591,2446048514609532,5612,6465408430000
       Other Current Liabilities 
0
0
0
0
70
24
42
78
663
1,279
121
195
256
70
387
1,984
593
2,356
2,046
1,525
1,310
1,626
1,760
1,619
3,158
2,666
4,670
4,6702,6663,1581,6191,7601,6261,3101,5252,0462,3565931,984387702561951211,279663784224700000
   > Long-term Liabilities 
0
0
0
0
0
1
8
45
77
371
864
48
72
4
7
0
3
2
0
0
1
35
42
48
74
123
52
521237448423510023074724886437177458100000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
38
60
0
0
00603810000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
1
35
42
10
14
20
0
02014104235100200000000000000000
> Total Stockholder Equity
-1
-81
20,729
21,393
16,678
15,777
38,467
19,515
8,735
5,611
9,888
3,750
5,229
6,931
5,623
13,975
37,686
39,113
31,367
23,690
16,081
16,555
10,548
30,470
35,469
22,813
13,798
13,79822,81335,46930,47010,54816,55516,08123,69031,36739,11337,68613,9755,6236,9315,2293,7509,8885,6118,73519,51538,46715,77716,67821,39320,729-81-1
   Common Stock
0
0
7,474
12,277
13,008
16,691
49,205
55,181
55,131
0
0
0
0
0
86,134
101,379
140,009
146,896
146,879
144,018
143,910
156,633
160,704
197,448
213,787
213,971
223,153
223,153213,971213,787197,448160,704156,633143,910144,018146,879146,896140,009101,37986,1340000055,13155,18149,20516,69113,00812,2777,47400
   Retained Earnings Total Equity000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
-145
-230
14,573
14,602
-49,266
-52,472
6,081
-526
-330
9,495
9,633
10,527
8,937
9,363
9,363
2,320
1,754
1,159
866
2,751
3,566
3,972
4,806
4,8063,9723,5662,7518661,1591,7542,3209,3639,3638,93710,5279,6339,495-330-5266,081-52,472-49,26614,60214,573-230-1450000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,363
0
0
0
0
0
0
0
0
0
0000000009,36300000000000000000
   Treasury Stock000000000000000000000000000
   Other Stockholders Equity 
-1
-81
13,255
9,116
14,814
14,848
0
0
0
53,977
69,992
77,842
84,032
82,341
86,134
0
0
12,065
12,065
2,320
1,754
1,159
-6,285
-27,720
-31,903
-18,840
0
0-18,840-31,903-27,720-6,2851,1591,7542,32012,06512,0650086,13482,34184,03277,84269,99253,97700014,84814,8149,11613,255-81-1



5.4. Balance Sheets

All numbers in thousands.




5.5. Cash Flows

All numbers in thousands.




5.6. Income Statements

All numbers in thousands.